SCHEMBL23408949

SCHEMBL23408949

COc1cc(CCc2cc(NC(=O)C3CCN(C)CC3)n[nH]2)cc(OC)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 8/20 0.55
PDGFRB P09619 2/20 0.55
NTRK1 P04629 1/20 0.55
RET P07949 1/20 0.55
MARK3 P27448 1/20 0.55
TNK2 Q07912 1/20 0.55
DDR1 Q08345 1/20 0.55
MAP4K2 Q12851 1/20 0.55
MAP3K11 Q16584 1/20 0.55
DDR2 Q16832 1/20 0.55
MARK2 Q7KZI7 1/20 0.55
MAP4K3 Q8IVH8 1/20 0.55
MAP4K1 Q92918 1/20 0.55
AURKB Q96GD4 1/20 0.55
EIF2AK1 Q9BQI3 1/20 0.55
MAP3K20 Q9NYL2 1/20 0.55
STK26 Q9P289 1/20 0.55
TNIK Q9UKE5 1/20 0.55
MAP4K5 Q9Y4K4 1/20 0.55
FGFR2 P21802 14/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25068890 0.90 FGFR1 (0.54) FGFR1PDGFRBNTRK1RETMARK3
SCHEMBL23408948 0.89 FGFR1 (0.54) FGFR1PDGFRBNTRK1RETMARK3
SCHEMBL23408946 0.84 FGFR1 (0.54) FGFR1PDGFRBNTRK1RETMARK3
SCHEMBL65188 0.83 FGFR1 (0.65) FGFR1PDGFRBNTRK1RETMARK3
SCHEMBL63882 0.79 FGFR1 (0.64) FGFR1PDGFRBNTRK1RETMARK3
SCHEMBL63000 0.79 FGFR1 (0.64) FGFR1PDGFRBNTRK1RETMARK3
SCHEMBL23808888 0.76 FGFR1 (0.69) FGFR1PDGFRBNTRK1RETMARK3
SCHEMBL21430743 0.74 FGFR1 (0.67) FGFR1PDGFRBNTRK1RETMARK3
SCHEMBL62513 0.74 FGFR1 (0.73) FGFR1PDGFRBNTRK1RETMARK3
SCHEMBL62894 0.73 FGFR1 (0.76) FGFR1PDGFRBNTRK1RETMARK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230055961-A1 PENTAFLUOROBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF DUNAD THERAPEUTICS LTD. (GB) 2023-02-23 US disclosed
WO-2021099842-A1 PENTAFLUOROBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 ONTARIO INC. (CA) 2021-05-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230055961-A1 PENTAFLUOROBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF FURIN, PFAS, CFTR FGFR1 109/4885PDGFRB 148/4885NTRK1 2721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.